Arbutus Biopharma Corp (NASDAQ: ABUS) is 4.23% higher on its value in year-to-date trading and has touched a low of $2.70 and a high of $4.72 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ABUS stock was last observed hovering at around $3.34 in the last trading session, with the day’s gains setting it 933.9%.
Currently trading at $937.24K, the stock is -7.00% and -4.37% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.71 million and changing 1713130% at the moment leaves the stock -8.80% off its SMA200. ABUS registered -2.14% loss for a year compared to 6-month gain of -0.31%. The firm has a 50-day simple moving average (SMA 50) of $3.3464 and a 200-day simple moving average (SMA200) of $3.5089.
The stock witnessed a -7.25% loss in the last 1 month and extending the period to 3 months gives it a -4.48%, and is -7.78% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.08% over the week and 3.84% over the month.
Arbutus Biopharma Corp (ABUS) has around 44 employees, a market worth around $612.89M and $6.40M in sales. Profit margin for the company is -1195.86%. Distance from 52-week low is 18.30% and -32.28% from its 52-week high. The company has generated returns on investments over the last 12 months (-90.95%).
with sales reaching $2.21M over the same period.The EPS is expected to grow by 34.74% this year, but quarterly earnings will post -11.10% year-over-year. Quarterly sales are estimated to shrink -7.39% in year-over-year returns.
222.0 institutions hold shares in Arbutus Biopharma Corp (ABUS), with institutional investors hold 76.02% of the company’s shares. The shares outstanding are 191.48M, and float is at 148.66M with Short Float at 8.64%. Institutions hold 59.38% of the Float.
The top institutional shareholder in the company is MORGAN STANLEY with over 20.96 million shares valued at $64.77 million. The investor’s holdings represent 11.1466 of the ABUS Shares outstanding. As of 2024-06-30, the second largest holder is WHITEFORT CAPITAL MANAGEMENT, LP with 12.87 million shares valued at $39.76 million to account for 6.8432 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 11.55 million shares representing 6.1434 and valued at over $35.7 million, while TWO SEAS CAPITAL LP holds 4.5584 of the shares totaling 8.57 million with a market value of $26.49 million.
